Latest Breaking News On - Analyst recommendations for theseus pharmaceuticals - Page 1 : comparemela.com

Theseus Pharmaceuticals (NASDAQ:THRX) Receives Outperform Rating from Wedbush

Wedbush reiterated their outperform rating on shares of Theseus Pharmaceuticals (NASDAQ:THRX – Free Report) in a research report sent to investors on Thursday, RTT News reports. The brokerage currently has a $7.00 target price on the stock. Wedbush also issued estimates for Theseus Pharmaceuticals’ Q1 2024 earnings at ($0.33) EPS, Q2 2024 earnings at ($0.35) […]

United statesCarll gordonStifel nicolausAmerican international group incAnalyst recommendations for theseus pharmaceuticalsTheseus pharmaceuticals incSecurities exchange commissionTheseus pharmaceuticals company profileTower research capitalCitigroup incNeedham companyHedge funds weigh in on theseus pharmaceuticalsBarclays plcTheseus pharmaceuticalsNews ratings for theseus pharmaceuticals dailyCantor fitzgerald

Wedbush Reiterates Outperform Rating for Theseus Pharmaceuticals (NASDAQ:THRX)

Wedbush Reiterates Outperform Rating for Theseus Pharmaceuticals (NASDAQ:THRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Carll gordonStifel nicolausNeedham companyInstitutional investors weigh in on theseus pharmaceuticalsCitigroup incYork mellon corpAnalyst recommendations for theseus pharmaceuticalsCharles schwab investment management incTheseus pharmaceuticalsCantor fitzgeraldDimensional fund advisorsPrincipal financial group incSecurities exchange commissionNews ratings for theseus pharmaceuticals dailyTheseus pharmaceuticals stock performanceTheseus pharmaceuticals inc

Wedbush Trims Theseus Pharmaceuticals (NASDAQ:THRX) Target Price to $7 00

Wedbush Trims Theseus Pharmaceuticals (NASDAQ:THRX) Target Price to $7 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesCharles schwab investment management incAmerican international group incNeedham companyTheseus pharmaceuticals incTheseus pharmaceuticals stock performanceTheseus pharmaceuticalsNews ratings for theseus pharmaceuticals dailyDeutsche bankTower research capitalHedge funds weigh in on theseus pharmaceuticalsAnalyst recommendations for theseus pharmaceuticalsFree reportModerate buyGet free reportResearch capital